期刊文献+

34例IgD型多发性骨髓瘤临床特点分析 被引量:12

原文传递
导出
摘要 多发性骨髓瘤(MM)是浆细胞异常增生的恶性肿瘤,其中IgD型是MM中较为少见的类型。现对我院初次诊治的34例IgD型MM患者临床资料进行回顾分析。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2011年第3期204-205,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献6

二级参考文献17

  • 1麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:27
  • 2陶中飞,傅卫军,陈玉宝,袁振刚,王东星,侯健.206例多发性骨髓瘤预后因素分析及分期评价[J].癌症,2006,25(4):461-464. 被引量:44
  • 3武永吉.多发性骨髓瘤//张之南,沈悌,血液病诊断及疗效标准,3版.北京:科学出版社,2007:232-235.
  • 4Blade J, SamsonD, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high dose therapy and hemopoietic stem cell transplantation. Myeloma Subcommittee of the EMBT. european group for blood and marrow transplant. Br J Haematol, 1998,102 : 1115-1123.
  • 5Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc, 2003, 78:21-33.
  • 6Blade J, Lust JA, Kyle RA. Immunoglobulin D multiple myeloma: Presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol, 1994, 12:2398-2404.
  • 7Shimamoto Y, Anami Y, Yamaguchi M. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Eur J Haematol, 1991,47:262-267.
  • 8Lin TL,Shih LY,Dunn P,et al.Iunoglobulin D multiple myeloma.Changgeng Yi Xue Za Zhi,2000,23:451-457.
  • 9Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic myeloma study group. Eur J Haematol,2000, 65:175-181.
  • 10霍夫曼.血液病学.基本原理与实践.第3版[M].北京:科学出版社,2001.1401-1492.

共引文献29

同被引文献90

  • 1周振海,罗绍凯,李娟,李小银,李幼姬,洪文德.多发性骨髓瘤本周蛋白基因可变区特点与肾小管功能损害的关系[J].中华内科杂志,2005,44(9):677-680. 被引量:7
  • 2陶中飞,傅卫军,陈玉宝,袁振刚,王东星,侯健.206例多发性骨髓瘤预后因素分析及分期评价[J].癌症,2006,25(4):461-464. 被引量:44
  • 3严云,汪萍,卞锦国,朱扬,沈霞,任梅玉.单克隆丙种球蛋白血症639例临床观察分析[J].中国实用内科杂志,2006,26(8):1164-1166. 被引量:6
  • 4周旭红,赖毅妍,庞缨,冯莹.伴mott细胞增多非分泌型多发性骨髓瘤1例[J].内科理论与实践,2007,2(2):133-134. 被引量:3
  • 5Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia,2006,20 : 1467- 1473.
  • 6Kirn SJ, Kim K, Kim BS, et al. Clinical features and survival outcomes in patients with multiple myeloma : analysis of web-based data from the Korean Myeloma Registry. Acta Haematol, 2009, 122:200-210.
  • 7Kim MK, Suh C, Lee DH, et al. Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients. Ann Oncol, 2011,22:411-416.
  • 8Pisani F, Petrucci MT, Giannarelli D, et al. IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy. J Exp Clin Cancer Res,2012,31:17.
  • 9Sekiguchi N, Takezako N, Nagata A, et al. Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapy. Intern Med, 2011,50:2653-2657.
  • 10Li K, Ku G, Yan M,et al. A rare and unique case of aggressive IgE-Xplasma cell myeloma in a 28-year-old woman presented initially as anorbital mass[ J] . Hum Pathol,2012 ,43 (12) :2376-2384.

引证文献12

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部